Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of…

A new report shows international regulators were unimpressed with Pfizer’s operations at a Hospira plant in India during a recent inspection.  

Pfizer has decided that it does not need the legacy distribution sites that it got with the $15 billion buyout of Hospira last year and so will close four…

Life sciences company Agilent Technologies recently will invest $120 million on anew plant in Colorado to make nucleic acid APIs.

Allergan, which this month completed the sale of its Actavis generics unit to Teva, is still cleaning up Actavis business, like the recall of tens of thousands…

The FDA has read the riot act to yet another Chinese drugmaker after finding it had been hiding batch tests results that showed high peaks of out-of-spec…

Piramal, like a number of its Indian compatriots, has decided it is a good idea to have manufacturing operations based in the U.S. and has now snapped up a…

Allergan’s superbug antibiotic Avycaz raked in $22.1 million in sales during H1. But it will be slow going for the rest of 2016 because of an issue with its…